Notice of Proposed Sale · 144
Abbott Laboratories
ABTNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- ABBOTT LABORATORIES
- Issuer CIK
- 0000001800
- SEC file number
- 001-02189
- Phone
- (224) 667-6100
- Person for whose account securities are to be sold
- Robert B. Ford
- Relationships to issuer
- Officer · Director
- Street
- 100 ABBOTT PARK ROAD
- City
- ABBOTT PARK
- State / country code
- IL
- Postal code
- 60064
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 398,832 | 46,204,386 | 1,730,383,296 | 08/25/2026 | NYSE | UBS Financial Services, Inc. |
Broker / market maker — proposed row 1, entry 1
- Name
- UBS Financial Services, Inc.
- Street
- 1000 Harbor Blvd.
- Street (continued)
- 3rd Floor
- City
- Weehawken
- State / country code
- NJ
- Postal code
- 07086
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/25/2026 | Exercise of Stock Options | Issuer | 398,832 | N | 08/25/2026 | Cash |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/25/2026
- Signed
- /s/ Aaron N. Rice, by Power of Attorney for Robert B. Ford
Company context
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com and on LinkedIn, Facebook, Instagram, X, and YouTube.